RhumbLine Advisers’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.74M | Sell |
83,768
-9,186
| -10% | -$331K | ﹤0.01% | 1781 |
|
|
2026
Q1 | $3.29M | Buy |
92,954
+1,483
| +2% | +$60.3K | ﹤0.01% | 1606 |
|
|
2025
Q4 | $3.71M | Sell |
91,471
-5,400
| -6% | -$235K | ﹤0.01% | 1549 |
|
|
2025
Q3 | $4.56M | Sell |
96,871
-2,733
| -3% | -$142K | ﹤0.01% | 1487 |
|
|
2025
Q2 | $5.19M | Buy |
99,604
+5,614
| +6% | +$308K | ﹤0.01% | 1398 |
|
|
2025
Q1 | $5.68M | Sell |
93,990
-334
| -0.4% | -$21.5K | 0.01% | 1292 |
|
|
2024
Q4 | $6.46M | Buy |
94,324
+3,486
| +4% | +$243K | 0.01% | 1290 |
|
|
2024
Q3 | $6.53M | Sell |
90,838
-2,402
| -3% | -$169K | 0.01% | 1274 |
|
|
2024
Q2 | $6.46M | Buy |
93,240
+590
| +0.6% | +$43K | 0.01% | 1250 |
|
|
2024
Q1 | $7.42M | Sell |
92,650
-2,326
| -2% | -$207K | 0.01% | 1204 |
|
|
2023
Q4 | $10.4M | Sell |
94,976
-3,979
| -4% | -$411K | 0.01% | 1035 |
|
|
2023
Q3 | $9.98M | Buy |
98,955
+793
| +0.8% | +$91.1K | 0.01% | 991 |
|
|
2023
Q2 | $13.3M | Buy |
98,162
+1,257
| +1% | +$153K | 0.01% | 869 |
|
|
2023
Q1 | $10.1M | Buy |
96,905
+3,732
| +4% | +$361K | 0.01% | 962 |
|
|
2022
Q4 | $8.26M | Buy |
93,173
+2,912
| +3% | +$242K | 0.01% | 1031 |
|
|
2022
Q3 | $7.24M | Buy |
90,261
+5,392
| +6% | +$509K | 0.01% | 1055 |
|
|
2022
Q2 | $8.13M | Buy |
84,869
+3,335
| +4% | +$400K | 0.01% | 1002 |
|
|
2022
Q1 | $12.1M | Buy |
81,534
+4,798
| +6% | +$670K | 0.02% | 859 |
|
|
2021
Q4 | $10.9M | Sell |
76,736
-671
| -0.9% | -$95K | 0.01% | 948 |
|
|
2021
Q3 | $10.1M | Sell |
77,407
-11,378
| -13% | -$1.49M | 0.01% | 943 |
|
|
2021
Q2 | $12.2M | Buy |
88,785
+494
| +0.6% | +$67.6K | 0.02% | 887 |
|
|
2021
Q1 | $11.5M | Buy |
88,291
+1,356
| +2% | +$163K | 0.02% | 899 |
|
|
2020
Q4 | $9.74M | Buy |
86,935
+3,522
| +4% | +$333K | 0.01% | 941 |
|
|
2020
Q3 | $6.56M | Sell |
83,413
-10,309
| -11% | -$841K | 0.01% | 993 |
|
|
2020
Q2 | $6.75M | Sell |
93,722
-4,181
| -4% | -$291K | 0.01% | 1005 |
|
|
2020
Q1 | $5.61M | Buy |
97,903
+649
| +0.7% | +$59.9K | 0.01% | 955 |
|
|
2019
Q4 | $10.9M | Buy |
97,254
+6,072
| +7% | +$647K | 0.02% | 786 |
|
|
2019
Q3 | $8.77M | Buy |
91,182
+5,598
| +7% | +$526K | 0.02% | 843 |
|
|
2019
Q2 | $7.32M | Buy |
85,584
+1,841
| +2% | +$151K | 0.01% | 966 |
|
|
2019
Q1 | $6.97M | Buy |
83,743
+1,057
| +1% | +$76.8K | 0.01% | 977 |
|
|
2018
Q4 | $5.31M | Buy |
82,686
+13,198
| +19% | +$903K | 0.01% | 1071 |
|
|
2018
Q3 | $5.5M | Hold |
69,488
| – | – | 0.01% | 1046 |
|
|
2018
Q2 | $5.09M | Sell |
69,488
-2,433
| -3% | -$165K | 0.01% | 1082 |
|
|
2018
Q1 | $4.55M | Buy |
71,921
+63
| +0.1% | +$3.76K | 0.01% | 1098 |
|
|
2017
Q4 | $3.66M | Buy |
71,858
+6,193
| +9% | +$323K | 0.01% | 1257 |
|
|
2017
Q3 | $3.44M | Buy |
65,665
+936
| +1% | +$47K | 0.01% | 1264 |
|
|
2017
Q2 | $3.3M | Sell |
64,729
-276
| -0.4% | -$13.7K | 0.01% | 1257 |
|
|
2017
Q1 | $2.89M | Buy |
65,005
+13,928
| +27% | +$599K | 0.01% | 1343 |
|
|
2016
Q4 | $2.26M | Sell |
51,077
-1,131
| -2% | -$48.1K | 0.01% | 1372 |
|
|
2016
Q3 | $2.09M | Buy |
52,208
+1,190
| +2% | +$50.5K | 0.01% | 1365 |
|
|
2016
Q2 | $2.44M | Sell |
51,018
-7,679
| -13% | -$325K | 0.01% | 1218 |
|
|
2016
Q1 | $2.46M | Buy |
58,697
+3,925
| +7% | +$154K | 0.01% | 1226 |
|
|
2015
Q4 | $2.41M | Buy |
54,772
+1,555
| +3% | +$67.5K | 0.01% | 1230 |
|
|
2015
Q3 | $2.54M | Buy |
53,217
+1,995
| +4% | +$110K | 0.01% | 1185 |
|
|
2015
Q2 | $2.98M | Sell |
51,222
-625
| -1% | -$33.7K | 0.01% | 1147 |
|
|
2015
Q1 | $2.62M | Buy |
51,847
+700
| +1% | +$34.3K | 0.01% | 1223 |
|
|
2014
Q4 | $2.3M | Buy |
51,147
+505
| +1% | +$21.2K | 0.01% | 1256 |
|
|
2014
Q3 | $1.87M | Buy |
50,642
+200
| +0.4% | +$7.93K | 0.01% | 1366 |
|
|
2014
Q2 | $2.23M | Sell |
50,442
-1,626
| -3% | -$73.7K | 0.01% | 1296 |
|
|
2014
Q1 | $2.26M | Sell |
52,068
-1,560
| -3% | -$69.5K | 0.01% | 1269 |
|
|
2013
Q4 | $2.28M | Sell |
53,628
-2,650
| -5% | -$101K | 0.01% | 1293 |
|
|
2013
Q3 | $1.91M | Sell |
56,278
-749
| -1% | -$24.4K | 0.01% | 1383 |
|
|
2013
Q2 | $1.78M | Buy |
+57,027
| New | +$1.85M | 0.01% | 1383 |
|
Other funds holding CNMD
ICM
RhumbLine Advisers's CNMD Position: Q2 2026 in Review
RhumbLine Advisers reduced its CONMED (CNMD) stake by 9.9% in Q2 2026, selling an estimated $331K and leaving 83,768 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1781.
RhumbLine Advisers first reported a position in CNMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.3M in Q2 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- RhumbLine Advisers held 83,768 shares of CONMED worth $2.74M as of Q2 2026.
- RhumbLine Advisers sold 9,186 CONMED shares in Q2 2026, an estimated $331K.
- CONMED made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1781 holding.
- RhumbLine Advisers first reported a position in CONMED in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's CONMED position peaked at $13.3M in Q2 2023.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.